Specify a stock or a cryptocurrency in the search bar to get a summary
Nyxoah
NYXHNyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Address: Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium, 1435
Analytics
WallStreet Target Price
15.98 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NYXH
Dividend Analytics NYXH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NYXH
Stock Valuation NYXH
Financials NYXH
Results | 2019 | Dynamics |